Wire Stories
-
617CHTF 2021 Exhibitions Showcase Leading High-Tech Solutions
SHENZHEN, China–(BUSINESS WIRE)–#5G–The ongoing 23rd China Hi-Tech Fair (CHTF) features 16 world-class exhibition areas taking place both online and on-site at the...
-
584
MyMD Pharmaceuticals Investment Company Oravax Medical Signs Cooperation and Purchase Agreement for Initial Pre-Purchase of 10 Million Doses of Oral COVID-19 Vaccine to be Commercialized in Southeast Asia
In addition to pre-purchase order, parties have agreed to negotiate potential follow-on orders that could be significant BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. (Nasdaq:...
-
712
Stratio, Inc. Partners With NIPA for All-New Advanced AI Vision System
AI Vision System to Provide Infringement Detection Against Similar Products of Registered Designs SAN JOSE, Calif.–(BUSINESS WIRE)–Stratio, Inc., a company that develops...
-
509
CORRECTING and REPLACING Chinese Enterprise By-Health Launches the First Personalized Customized Vitamin Concept Product, Leading the Industrialization of Precision Nutrition
ZHUHAI, China–(BUSINESS WIRE)–Please replace the release dated December 22, 2021 with the following corrected version due to multiple revisions. The updated release...
-
675
Samsung SDI Launches Battery Brand PRiMX
– Provides the best experience with the top-quality battery – Unveiled PRiMX, a battery brand conveying Samsung SDI�s unique identity – Developed...
-
520Gilat Signs Multi-Million Dollar Deal to Modernize and Expand Satellite Communications in Eurasia for Multiple Applications
Gilat’s SkyEdge II-c was chosen as the platform to enhance maritime, land mobility, and consumer applications PETAH TIKVA, Israel, Dec. 29, 2021...
-
557
Bio-Thera Solutions Announces Initiation of Phase I Clinical Trials for BAT6026, a Monoclonal Antibody Targeting OX40
GUANGZHOU, China–(BUSINESS WIRE)–#ADCC–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase I clinical study...
-
551
Bio-Thera Solutions Announces Initiation of Phase I Clinical Trials for BAT6005, a Monoclonal Antibody Targeting TIGIT
GUANGZHOU, China–(BUSINESS WIRE)–#BAT6005–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in Phase I clinical study...
-
533Stipulation of Partial Judgment In Favor of Liquidia Filed In Hatch-Waxman Litigation
MORRISVILLE, N.C., Dec. 29, 2021 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) announced today that United Therapeutics Corporation (UTC) has filed a...
-
596
Indian Dyes & Pigments Market Growth and Forecasts 2021-2027, by – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Indian Dyes & Pigments Market 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Indian Dyes & Pigments market is...
